Pharma channel feed – Endpoints News

Pharma channel feed

PEOTUS Donald Trump vows to rein in drug prices, slamming biotech stocks

9 years ago

Is the US biopharma industry headed for a turning point in 2017?

9 years ago

Sarepta critic Jenkins is exiting the FDA, and Woodcock takes direct charge of the OND after a painful rupture

9 years ago

Rattled by immune responses, Spark will pay $30M-plus to get Selecta’s help in ending threat

9 years ago

Booming CRISPR pioneer Intellia looks to double staff with new digs

9 years ago

Round 2 in Boehringer's US reorganization will claim another 244 jobs, including small molecule group

9 years ago

Merck pulls the trigger on a new West Coast R&D campus in the heart of a mega-hub

9 years ago

Star-crossed AstraZeneca strikes a drug discovery deal with upstart Bicycle

9 years ago

21st Century Cures Act supporters crush meager House opposition, head to a final showdown in the Senate

9 years ago

In Lechleiter's final days, Eli Lilly flags upcoming job cuts in the wake of a PhIII implosion

9 years ago

Stubborn Actelion CEO Clozel spurs shift in buyout talks, but J&J counters with a raised bid -- reports

9 years ago

House lines up biotech lollipops as support grows for an epic 21st Century Cures Act

9 years ago

Will J&J come up with a big enough treasure trove to win an Actelion buyout?

9 years ago

Novartis swoops in to bag Selexys and its sickle cell drug in $665M deal

9 years ago

Dinner and a biotech chat: Billionaire Patrick Soon-Shiong talks 'innovation' with President-elect Trump

9 years ago

Donald Trump is starting to win over biopharma

9 years ago

Florida's decade-old incentive program to lure research institutions is going belly up

9 years ago

AbbVie, Enanta hep C combo looks stellar in CKD study as rivals hustle along the latest cures

9 years ago

Biotech insider Rich Bagger is out, Gingrich is up in latest reshuffle of Trump’s inner circle

9 years ago

Donald Trump sends a vaguely worded love letter to biopharma as stock rally continues

9 years ago

Bristol-Myers hands over $100M in cash for a new fibrosis drug, beefing up NASH focus

9 years ago

Kite gives itself a little more time to finish FDA application for KTE-C19

9 years ago

Biopharma shares rally as Donald Trump scores a stunning upset

9 years ago

Prop 61 goes down in flames, torching a national drug price control model

9 years ago

First page Previous page 334 335 336337338 339 340 Next page Last page